/PRNewswire/ Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer.
/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Piper Sandler 34th Annual.
SOMERSET, N.J. (BUSINESS WIRE) Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:Event: BMO Biopharma Spo.
Legend Biotech Announces Participation in Upcoming Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
WESTLAKE VILLAGE, Calif., March 02, 2022 Arcutis Biotherapeutics, Inc. , a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today. | March 2, 2022